Updates are available Correction dated 2023-08-14
Click to view Correction: https://0-doi-org.brum.beds.ac.uk/10.1186/s10194-023-01647-5
-
Authors
Scutelnic, Adrian
Drangova, Hristina
Klein, Antonia
Slavova, Nedelina
Beyeler, Morin
Lippert, Julian
Silimon, Norbert
Meinel, Thomas R.
Arnold, Marcel
Fischer, Urs
Riederer, Franz
Mattle, Heinrich P.
Jung, Simon
Schankin, Christoph J.
-
Funding
Funding for this research was provided by:
Schweizerische Herzstiftung (FF21070, FF21070, FF21070)
- License Information
-
More Information
Article History
Received: 23 June 2023
Accepted: 27 July 2023
First Online: 1 August 2023
Change Date: 14 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://0-doi-org.brum.beds.ac.uk/10.1186/s10194-023-01647-5
Declarations
:
: HD, NS, MB, JL, FR: none; AS and SJ report research support from the Swiss Heart Foundation. AK has received research support from the Bangerter-Rhyner Foundation. UF: consulting for Medtronic, Stryker, CSL Behring. Advisory boards for Portola/Alexion (money paid to institution). MA reports personal fees from AstraZeneca, Bayer, Bristol Myers Squibb, Covidien, Daiichy Sankyo, Medtronic, Novartis, Pfizer, and Amgen. HPM: Grants from Abbott for the PC and PRIMA trials and from Cerenovus for the ARISE studies. Personal and speaker fees from Cerenovus, Bayer, Servier, Medtronic and Stryker. CJS: consulting, advisory boards, speaker, travel support for/from Novartis, Eli Lilly, TEVA Pharmaceuticals, Allergan, Almirall, Amgen, Lundbeck, MindMed, Grünenthal. Part-time-employee at Zynnon.
